NWPF

News ArchivesRead News

Your Weekly Parkinson's News Update for the Week of 11.26.18

Monday November 26, 2018
World-First Pill May Stop Parkinson’s
The New Daily
A new therapy that appears to stop Parkinson’s “in its tracks” will begin phase-one clinical trials in humans next year. The therapy, developed by researchers at the University of Queensland – and partly under-written by the Michael J Fox Foundation – is a world first because it stops the death of brain cells in Parkinson’s sufferers rather than managing symptoms. If human trials echo the stunning results in animal testing, the inflammation of the brain that causes so much of the progressive damage in Parkinson’s disease (PD) could be halted by taking a single pill each day.
Insulin Resistance and Parkinson's
News-Medical Life Sciences
"Insulin resistance is defined as a condition wherein tissues in the body stop responding to insulin, resulting in impaired glucose and energy metabolism. A growing pool of evidence suggests that a similar pattern of metabolic dysregulation is also observed in patients with Parkinson's".
Exercise That Motivates Parkinson’s Patients to Push Limits
Can Offer Range of Benefits, Experts Say
Parkinson's News Today
"Many consider it common sense that exercise can help to compensate for the motor symptoms that mark Parkinson’s — and research points to this possibility—yet scientists still have few clues as to how exactly it does so.
Work done through the Parkinson’s Outcome Project, an ongoing study involving more than 12,000 patients in five countries, suggests that patients should exercise at least 2.5 hours each week to slow decline and maintain a better quality of life. A similar study advised that patients should begin regular exercise at diagnosis."